218 related articles for article (PubMed ID: 26325208)
1. Identification of module biomarkers from the dysregulated ceRNA-ceRNA interaction network in lung adenocarcinoma.
Shao T; Wu A; Chen J; Chen H; Lu J; Bai J; Li Y; Xu J; Li X
Mol Biosyst; 2015 Nov; 11(11):3048-58. PubMed ID: 26325208
[TBL] [Abstract][Full Text] [Related]
2. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
[TBL] [Abstract][Full Text] [Related]
4. CERNA SEARCH METHOD IDENTIFIED A MET-ACTIVATED SUBGROUP AMONG EGFR DNA AMPLIFIED LUNG ADENOCARCINOMA PATIENTS.
Kabat H; Tunkle L; Lee I
Pac Symp Biocomput; 2017; 22():438-448. PubMed ID: 27896996
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
[TBL] [Abstract][Full Text] [Related]
6. Construction and Analysis of lncRNA-Mediated ceRNA Network in Cervical Squamous Cell Carcinoma by Weighted Gene Co-Expression Network Analysis.
Chen W; Chen X; Wang Y; Liu T; Liang Y; Xiao Y; Chen L
Med Sci Monit; 2019 Apr; 25():2609-2622. PubMed ID: 30965350
[TBL] [Abstract][Full Text] [Related]
7. Identification of laryngeal cancer prognostic biomarkers using an inflammatory gene-related, competitive endogenous RNA network.
He Q; Tian L; Jiang H; Zhang J; Li Q; Sun Y; Zhao J; Li H; Liu M
Oncotarget; 2017 Feb; 8(6):9525-9534. PubMed ID: 27902487
[TBL] [Abstract][Full Text] [Related]
8. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
[TBL] [Abstract][Full Text] [Related]
9. The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer.
Liu D; Yu X; Wang S; Dai E; Jiang L; Wang J; Yang Q; Yang F; Zhou S; Jiang W
Oncotarget; 2016 Aug; 7(35):57228-57238. PubMed ID: 27528026
[TBL] [Abstract][Full Text] [Related]
10. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
11. Detection of dysregulated competing endogenous RNA modules associated with clear cell kidney carcinoma.
Wang H; Xu D; Huang H; Cui Y; Li C; Zhang C; Guo S; Zhang L; Xu X; Xu J; Lu J; Wang L; Li K
Mol Med Rep; 2018 Aug; 18(2):1963-1972. PubMed ID: 29956728
[TBL] [Abstract][Full Text] [Related]
12. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
13. The mRNA related ceRNA-ceRNA landscape and significance across 20 major cancer types.
Xu J; Li Y; Lu J; Pan T; Ding N; Wang Z; Shao T; Zhang J; Wang L; Li X
Nucleic Acids Res; 2015 Sep; 43(17):8169-82. PubMed ID: 26304537
[TBL] [Abstract][Full Text] [Related]
14. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers.
Tran N; Abhyankar V; Nguyen K; Weidanz J; Gao J
BMC Bioinformatics; 2018 Dec; 19(Suppl 20):504. PubMed ID: 30577741
[TBL] [Abstract][Full Text] [Related]
16. Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
Chiu YC; Hsiao TH; Chen Y; Chuang EY
BMC Genomics; 2015; 16 Suppl 4(Suppl 4):S1. PubMed ID: 25917195
[TBL] [Abstract][Full Text] [Related]
17. Competing endogenous RNAs in lung cancer.
Zhao M; Feng J; Tang L
Cancer Biol Med; 2021 Feb; 18(1):1-20. PubMed ID: 33628581
[TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Prognostic Biomarkers for Breast Cancer Based on lncRNA-TF-Associated ceRNA Network and Functional Module.
Li X; Zhu J; Qiu J
Biomed Res Int; 2020; 2020():5257896. PubMed ID: 32802855
[TBL] [Abstract][Full Text] [Related]
19. Revealing potential long non-coding RNA biomarkers in lung adenocarcinoma using long non-coding RNA-mediated competitive endogenous RNA network.
Zhu TG; Xiao X; Wei Q; Yue M; Zhang LX
Braz J Med Biol Res; 2017 Aug; 50(9):e6297. PubMed ID: 28793054
[TBL] [Abstract][Full Text] [Related]
20. Construction of a ceRNA network reveals potential lncRNA biomarkers in rectal adenocarcinoma.
Zhang Z; Wang S; Ji D; Qian W; Wang Q; Li J; Gu J; Peng W; Hu T; Ji B; Zhang Y; Wang S; Sun Y
Oncol Rep; 2018 May; 39(5):2101-2113. PubMed ID: 29512732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
